Table 3. Logistic regression model for pharmacists supporting the legislation to make PSE available by prescription only (n = 342).

	Odds ratio (95% CI)	Pvalue
Practice site
Independent pharmacists	…
Chain pharmacists	2.90 (1.27–6.60)	0.011
Anticipated impact on time spent on PSE activities
Increase in time	…
No change in time	5.09 (1.77–14.65)	0.003
Decrease in time	10.57 (4.42–25.30)	<0.001
Anticipated impact on pharmacy profits
Reduced profits	…
Increased profits	9.45 (1.80–49.5)	0.008
Neutral financial impact	4.53 (1.64–12.45)	0.003
Uncertain	3.78 (1.27–11.26)	0.017
Regions
Region 1	…
Region 2	4.57 (1.34–15.59)	0.015
Region 3	1.89 (0.66–5.44)	0.235
Region 4	8.17 (1.71–39.03)	0.008
Region 5	4.04 (1.19–13.79)	0.025
Region 6	7.99 (2.34–27.30)	0.001
Perceived efficacy of reducing methamphetamine abuse
Not effective	…
Somewhat ineffective	1.52 (0.26–9.02)	0.646
Somewhat effective	8.22 (1.94–34.93)	0.004
Very effective	34.05 (5.89–196.97)	<0.001
Perceived efficacy of reducing methamphetamine lab incidents
Not effective	…
Somewhat ineffective	2.26 (0.38–13.55)	0.372
Somewhat effective	2.56 (0.70–9.32)	0.155
Very effective	8.47 (1.68–42.60)	0.010
No opinion	4.92 (0.56–43.54)	0.152
Confidence in identifying patients using PSE for a legitimate purpose
Extremely confident	…
Somewhat confident	0.67 (0.30–1.54)	0.349
Not confident	0.81 (0.14–4.58)	0.810
Not applicable	0.81 (0.05–13.54)	0.883
Grams of PSE sold per county resident	0.51 (0.13–1.99)	0.336

Abbreviation used: PSE, pseudoephedrine.